Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Management of Severe Riga-Fede Disease in a Child With MIRAGE Syndrome
Kolapo Dairo1, Neil Mehta2,3, Jonathan Grischkan3,2
1Department of Otolaryngology, The Ohio State University College of Medicine, Columbus, USA.
Abstract:
Riga-Fede disease (RFD) is a rare condition in infants and young children caused by repetitive trauma to the oral mucosa, often from newly erupted teeth. We present the case of a 13-month-old male child with a complex genetic disorder who developed persistent ulceration on the ventral tongue due to contact with mandibular incisors. Initial management included conservative smoothing of the teeth, which led to only partial improvement. Over time, the mucosal ulceration worsened, resulting in mucosal separation and soft tissue loss. A multidisciplinary surgical approach was pursued. Pediatric otolaryngology performed excision of the compromised mucosa, re-approximation of the muscular defect with absorbable sutures, and a lingual frenuloplasty to address ankyloglossia. Pediatric dentistry completed the extraction of the four mandibular incisors to eliminate the source of trauma. This case illustrates the importance of early recognition and definitive treatment of RFD to prevent progression to more complex soft tissue defects. In medically complex patients, delays in intervention may lead to increased morbidity and impaired healing. Successful management requires close collaboration between specialties and careful surgical planning to preserve function and reduce recurrence risk.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Mitral Stenosis III: Medical Management
Angle Closure Glaucoma: Treatment
Rheumatic Heart Disease III: Medical Management
Mitral Regurgitation III: Medical Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

